6-K 1 tm2213653d1_6k.htm FORM 6-K

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE
SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2022

 

Commission File Number: 001-40413

 

 

Quipt Home Medical Corp. 

(Translation of registrant’s name into English)

 

 

1019 Town Drive 

Wilder, Kentucky 41076 

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  ¨                Form 40-F  x

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

 

 

EXHIBIT INDEX

 

     
Exhibit   Description
99.1   Amended Condensed Consolidated Interim Financial Statements and notes thereto as at and for the three months ended December 31, 2021 and 2020
99.2   Amended Management’s Discussion and Analysis for the three months ended December 31, 2021
99.3   Form 52-109F2R - Certification of Refiled Interim Filings (CEO) dated April 26, 2022
99.4   Form 52-109F2R - Certification of Refiled Interim Filings (CFO) dated April 26, 2022
99.5   News Release dated April 26, 2022

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Quipt Home Medical Corp.
   
Date: April 27, 2022 /s/ Gregory Crawford
  Chief Executive Officer